Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877251362762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Fatih Canan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Down Syndrome, Neurodegenerative Diseases, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, UT Southwestern Winspear Family Center for Research on the Neuropathology of Alzheimer Disease, McCune Charitable Foundation.
Abstract (Originalsprache)
Background
Down syndrome (DS) is frequently associated with Alzheimer's disease neuropathologic change (ADNC). However, studies assessing the full spectrum of neurodegenerative pathologies using modern consensus and staging criteria remain limited.
Objective
We aimed to elucidate the progression of neurodegenerative pathologies in DS and to explore the prevalence of comorbid pathologies across a broad age range (0–76 years), using comprehensive neuropathological assessments.
Methods
We conducted a two-phase analysis. First, we investigated an institutional dataset, followed by a pooled analysis incorporating data from the National Alzheimer's Coordinating Center and four published studies. Pathologies assessed included amyloid-β (Aβ), tau, α-synuclein, TDP-43, cerebral amyloid angiopathy (CAA), other cerebrovascular diseases (CVD), hippocampal sclerosis (HS), and basal ganglia mineralizations (BGM).
Results
Diffuse Aβ plaques appeared by age 11, with neuritic plaques emerging in the mid-thirties. Mild tau pathology, including pre-tangles and neuropil threads, first emerged in the second decade, with neurofibrillary tangles fully present in the fourth decade, always concurrent with Aβ plaques. All individuals over 30 exhibited ADNC. α-Synuclein pathology was observed in 27% of cases, while aging-related tau astrogliopathy (ARTAG), HS, and limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) were rare. CVD was present in approximately 60%, CAA was nearly universal (98%) after age 50, and 18% had BGM. Brain weight was consistently below the 25th percentile, even in younger individuals without ADNC.
Conclusions
DS shows a distinct neurodegenerative trajectory with early Aβ deposition. CAA, arteriolosclerosis, BGM, and α-synuclein pathology were highly prevalent, while ARTAG and LATE-NC were infrequently observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
- Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA.
- Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
ORCID-Profile: Fatih Canan, Timothy E Richardson, Elena V Daoud
Förderung
- NIA NIH HHS
- UT Southwestern Winspear Family Center for Research on the Neuropathology of Alzheimer Disease
- McCune Charitable Foundation
Zitieren
APA
Canan, F., Wick, N., Raisanen, J. M., Burns, D. K., Hatanpaa, K. J., Richardson, T. E., White, C. L., & Daoud, E. V. (2025). Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251362762
Vancouver
Canan F, Wick N, Raisanen JM, Burns DK, Hatanpaa KJ, Richardson TE, et al. Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251362762
BibTeX
@article{Canan2025,
author = {Canan, Fatih and Wick, Neda and Raisanen, Jack M and Burns, Dennis K and Hatanpaa, Kimmo J and Richardson, Timothy E and White, Charles L and Daoud, Elena V},
title = {Characterization of neurodegenerative pathologies in adult and pediatric subjects with Down syndrome},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877251362762}
}
EUVIMED